Axogen, Inc. AXGN
Set alert
At close
Pre-market · Nov 2, 9:06 AM ET
- YTD
- +50.84%
- 1 year
- +117.68%
- Open
- 49.70
- Prev close
- 49.37
- Mkt cap
- 2.95B
- Vol
- 1.84M
- Avg vol
- 1.39M
- EPS
- -0.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 48.08
- High
- 49.88
- Forward P/E
- 69.55
- Beta
- 1.17
- Short ratio
- 3.57
- Inst. own
- 95.98%
- Dividend
- 0.00
- Ex-div date
- Jan 26, 2010
- Earnings
- Feb 23, 2027
- 50-d avg
- 42.80
- 200-d avg
- 39.48
- 1y target
- 57.73
News
2 days ago seekingalpha.com
Axogen: Taking The Friction Out Of Nerve Repair
Axogen (AXGN) is evolving from a growth story to the default procedural platform in peripheral nerve repair, protected by a regulatory moat for the next decade. Q3 2026 saw 26% revenue growth, 45%…
-
3 days ago benzinga.com
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $60
Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $55 to $60.
-
3 days ago benzinga.com
Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $56
Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $52 to $56.
-
3 days ago benzinga.com
Barclays Maintains Overweight on Axogen, Raises Price Target to $60
Barclays analyst Christopher Pasquale maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $50 to $60.
3 days ago zacks.com
Is AxoGen (AXGN) Outperforming Other Medical Stocks This Year?
Here is how AxoGen (AXGN) and BioCryst Pharmaceuticals (BCRX) have performed compared to their sector so far this year.
-
3 days ago benzinga.com
Truist Securities Maintains Buy on Axogen, Raises Price Target to $60
Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $60.
-
4 days ago benzinga.com
Wells Fargo Maintains Overweight on Axogen, Raises Price Target to $56
Wells Fargo analyst Larry Biegelsen maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $48 to $56.
4 days ago benzinga.com
Microsoft To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday
Analysts raised targets for Microsoft, VF, Glaukos, Hilton, AxoGen and Brinker; Renasant’s target was cut and its rating downgraded.
-
4 days ago benzinga.com
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $56
HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $56.
4 days ago marketbeat.com
AxoGen Q3 Earnings Call Highlights
AxoGen NASDAQ: AXGN reported third-quarter revenue growth of 26.2% as demand for its nerve-repair products increased across its breast, extremities, oral and maxillofacial, and head-and-neck markets.…
4 days ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular session. The company's market cap stands at $85.0 million. As per the press release, Q3 earnings came out…
4 days ago benzinga.com
Crude Oil Surges Over 3%; Brinker Posts Upbeat Earnings
U.S. stocks were mixed; Dow and S&P 500 rose while Nasdaq slipped. Brinker beat estimates and raised guidance; oil jumped 3.4%.
4 days ago seekingalpha.com
Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript
Axogen, Inc. (AXGN) Q3 2026 Earnings Call Transcript
4 days ago benzinga.com
Vertiv, Evercore, Brinker, GE HealthCare And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed; Dow gained ~100 points. Vertiv jumped 13.3% on strong results and raised guidance; Ultralife soared 145.8% on buyout news.
5 days ago zacks.com
AxoGen (AXGN) Beats Q3 Earnings and Revenue Estimates
AxoGen (AXGN) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.12 per share a year ago.
5 days ago benzinga.com
Axogen Q3 2026 Earnings Call Transcript
Axogen (NASDAQ:AXGN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
5 days ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q3 earnings report…
-
5 days ago benzinga.com
Axogen Q3 Adj. EPS $0.21 Beats $0.14 Estimate, Sales $75.834M Beat $73.199M Estimate
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.14 by 50 percent. This is a 75 percent increase over earnings of $0.12 per share…
5 days ago globenewswire.com
Axogen, Inc. Reports Third Quarter 2026 Financial Results
Raises Full Year Revenue Guidance to at Least 29% Growth or $290 million Raises Full Year Revenue Guidance to at Least 29% Growth or $290 million
-
1 week ago benzinga.com
Barclays Maintains Overweight on Axogen, Lowers Price Target to $50
Barclays analyst Christopher Pasquale maintains Axogen (NASDAQ:AXGN) with a Overweight and lowers the price target from $55 to $50.
1 week ago zacks.com
AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 weeks ago zacks.com
GMED or AXGN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or AxoGen (AXGN). But which of these two stocks offers value investors a better…
2 weeks ago globenewswire.com
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
ALACHUA, Fla. and TAMPA, Fla.
3 weeks ago benzinga.com
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.
-
3 weeks ago benzinga.com
B of A Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $52
B of A Securities analyst Travis Steed initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $52.
3 weeks ago zacks.com
Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)
The heavy selling pressure might have exhausted for AxoGen (AXGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in…
1 month ago prnewswire.com
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
/PRNewswire/ -- Stock Preachers News Commentary - Big technology names pulled the Nasdaq Composite to a weekly gain while the Dow Jones Industrial Average and
1 month ago globenewswire.com
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
ALACHUA, Fla. and TAMPA, Fla.
-
1 month ago benzinga.com
Truist Securities Maintains Buy on Axogen, Lowers Price Target to $53
Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and lowers the price target from $60 to $53.
1 month ago benzinga.com
AMD To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday
Analysts cut targets for GWW, IE and COST, while raising targets for OKTA, AXGN, ZS and DRI; ratings remained unchanged.
-
1 month ago benzinga.com
Raymond James Maintains Outperform on Axogen, Raises Price Target to $53
Raymond James analyst Jayson Bedford maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $48 to $53.
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 month ago gurufocus.com
Axogen Inc (AXGN) Shares Fall 3.0% -- GF Value Says Still Overvalued
On September 22, 2026, Axogen Inc (AXGN) shares fell by 3.0%, closing at $44.54. The stock is currently trading within a 52-week range of $15.27 to $52.91.
1 month ago benzinga.com
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Axogen Inc. (NASDAQ:AXGN) on Thursday agreed to acquire a privately held medical device manufacturer, BioCircuit Technologies Inc., for $200 million in cash.
1 month ago benzinga.com
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Axogen is acquiring BioCircuit Technologies for $200 million to add sutureless NerveTape to its portfolio, funded by a public stock offering.
1 month ago schaeffersresearch.com
2 Medical-Device Stocks Lighting Up the Options Pits
Medical-device stocks Cooper Companies Inc (NASDAQ:COO) and Axogen Inc (NASDAQ:AXGN) are both sharply lower following separate company developments, and options traders are chiming in.
1 month ago seekingalpha.com
Axogen, Inc. (AXGN) M&A Call Transcript
Axogen, Inc. (AXGN) M&A Call Transcript
-
1 month ago benzinga.com
Axogen Prices $208.7M Underwritten Public Offering Of 4.91M Shares At $42.50 Per Share
Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the
-
1 month ago benzinga.com
Axogen To Acquire NerveTape Maker BioCircuit Technologies For $200M In Cash; Sees Deal As Accretive To FY27 Gross And Adjusted EBITDA Margins
At closing, $1.0 million of the estimated merger consideration will be withheld pending determination of the post-closing purchase price adjustment. The transaction is expected to close in the fourth…
1 month ago globenewswire.com
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
ALACHUA, Fla. and TAMPA, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions…
1 month ago globenewswire.com
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen's addressable market within its focus markets
2 months ago globenewswire.com
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
ALACHUA, Fla. and TAMPA, Fla.
2 months ago gurufocus.com
Axogen Inc (AXGN) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 64/100
On August 26, 2026, Axogen Inc (AXGN) shares rose 3.3% to a current price of $51.58, continuing a strong upward trend. Over the past year, the stock has surged
-
2 months ago benzinga.com
Truist Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $60
Truist Securities analyst Ravi Misra initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $60.
-
3 months ago benzinga.com
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $55
Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $50 to $55.
-
3 months ago benzinga.com
Citizens Maintains Market Outperform on Axogen, Raises Price Target to $55
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $50 to $55.
-
3 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $53
HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $50 to $53.
-
3 months ago benzinga.com
Axogen Participates In Series A Funding Round For Trace Biosciences With Additional Investors Expected To Join; Terms Not Disclosed
Nerve Trace is a near-infrared fluorescence imaging technology designed to provide direct, real-time visualization of nerves during surgery, including nerves that are otherwise obscured from view by…
-
3 months ago benzinga.com
Axogen Q2 Adj. EPS $0.12 Misses $0.13 Estimate, Sales $69.731M Beat $67.098M Estimate
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.13 by 7.69 percent. This is unchanged from the same period last year. The company…
-
6 months ago benzinga.com
Citizens Maintains Market Outperform on Axogen, Raises Price Target to $50
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $42 to $50.